Transverse myelitis after anti-CD19 directed CAR T cell therapy for relapsed large B cell lymphoma

EJHaem. 2021 Dec 6;3(1):223-227. doi: 10.1002/jha2.286. eCollection 2022 Feb.

¹ Division of Medical Oncology and Hematology University Health Network Toronto Canada.
² Department of Neuro-Oncology Moffitt Cancer Center Tampa Florida USA.
³ Department of Hematology North York General Hospital Toronto Canada.
⁴ Department of Hematology Moffitt Cancer Center Tampa Florida USA.
⁵ Department of Malignant Hematology Moffitt Cancer Center Tampa Florida USA.
⁶ Department of Blood & Marrow Transplant and Cellular Immunotherapy Moffitt Cancer Center Tampa Florida USA.
⁷ Division of Medical Oncology and Hematology Princess Margaret Hospital Toronto Canada.
⁸ Department of Neurology North York General Hospital Toronto Canada.

No abstract available

Keywords: CAR T cell therapy; ICANS; neurotoxicity; transverse myelitis.

Publication types